Kolexia
Willems Lise Hématologie
Willems Lise
Hématologie
Hôpital Cochin
Paris, France
133 Activités
104 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Syndromes myélodysplasiques Lymphomes Leucémie aigüe myéloïde Leucémie myéloïde Leucémie chronique lymphocytaire à cellules B Leucémie myélomonocytaire chronique Tumeurs du système nerveux central Tumeurs hématologiques

Collaborateurs

Voir plus
Bouscary Didier
Bouscary Didier
Hôpital Cochin, Paris, France
Chapuis Nicolas
Chapuis Nicolas
Hôpital Cochin, Paris, France
Tamburini-Bonnefoy Jerome
Tamburini-Bonnefoy Jerome
Hôpital Cochin, Paris, France
Deau Fischer Bénédicte
Deau Fischer Bénédicte
Hôpital Cochin, Paris, France

Industries

Voir plus
Abbvie
12 collaboration(s)
Dernière en 2023
Janssen
8 collaboration(s)
Dernière en 2023
Novartis
6 collaboration(s)
Dernière en 2023
AstraZeneca
3 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Interim FDG-PET improves treatment failure prediction in primary central nervous system Lymphoma: a LOC network prospective multicentric study.
Neuro-oncology   16 février 2024
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation.
Nature communications   30 janvier 2024
Autoimmune myelofibrosis: clinical and histological efficacy of ciclosporin treatment.
BMJ case reports   24 janvier 2024
LOC-R01: Randomized Phase IB/II Study of Escalating Doses of Lenalidomide and Ibrutinib in Association With R-MPV as a Targeted Induction Treatment for Patients Aged 18 to 60 (up to 65 for Phase II) With a Newly Diagnosed Primary Central Nervous System Lymphoma
Essai Clinique (Institut Curie)   10 janvier 2024
Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA: A Randomized Phase I/ II Multicenter Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA
Essai Clinique (Celgene)   02 janvier 2024
Evolution of radiotherapy techniques for mediastinal Hodgkin lymphoma: a single-center experience.
Mediastinum (Hong Kong, China)   07 décembre 2023
Efficacy and Safety of Luspatercept +/- Erythropoiesis-Stimulating Agent (ESA) in Patients with Myelodysplastic Syndromes with Ring Sideroblasts (MDS-RS): A French Multicenter Prospective Real-Life Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
RCHOP Plus High-Dose Methotrexate As First-Line Therapy in Large B-Cell Lymphoma with Testis Involvement
65th ASH Annual Meeting Abstracts   02 novembre 2023
Efficacy of Chemo-Free Combination Therapy with BRAF Inhibitor and Rituximab in Classic Hairy Cell Leukemia: Insights from the French Experience
65th ASH Annual Meeting Abstracts   02 novembre 2023
Subcutaneous azacitidine maintenance in transplantineligible patients with acute myeloid leukemia: a single-center retrospective study.
Haematologica   01 octobre 2023